Developmental Biomedicine Research Group, University of Manchester, Manchester, United Kingdom.
PLoS One. 2011;6(7):e22289. doi: 10.1371/journal.pone.0022289. Epub 2011 Jul 29.
The glucocorticoid receptor (GR) is a member of the nuclear hormone receptor superfamily of ligand-activated transcription factors. In contrast to many other nuclear receptors, GR is thought to be exclusively cytoplasmic in quiescent cells, and only translocate to the nucleus on ligand binding. We now demonstrate significant nuclear GR in the absence of ligand, which requires nuclear localisation signal 1 (NLS1). Live cell imaging reveals dramatic GR import into the nucleus through interphase and rapid exclusion of the GR from the nucleus at the onset of mitosis, which persists into early G(1). This suggests that the heterogeneity in GR distribution is reflective of cell cycle phase. The impact of cell cycle-driven GR trafficking on a panel of glucocorticoid actions was profiled. In G2/M-enriched cells there was marked prolongation of glucocorticoid-induced ERK activation. This was accompanied by DNA template-specific, ligand-independent GR transactivation. Using chimeric and domain-deleted receptors we demonstrate that this transactivation effect is mediated by the AF1 transactivation domain. AF-1 harbours multiple phosphorylation sites, which are consensus sequences for kinases including CDKs, whose activity changes during the cell cycle. In G2/M there was clear ligand independent induction of GR phosphorylation on residues 203 and 211, both of which are phosphorylated after ligand activation. Ligand-independent transactivation required induction of phospho-S211GR but not S203GR, thereby directly linking cell cycle driven GR modification with altered GR function. Cell cycle phase therefore regulates GR localisation and post-translational modification which selectively impacts GR activity. This suggests that cell cycle phase is an important determinant in the cellular response to Gc, and that mitotic index contributes to tissue Gc sensitivity.
糖皮质激素受体(GR)是核激素受体超家族的配体激活转录因子成员。与许多其他核受体不同,GR 在静止细胞中被认为仅存在于细胞质中,只有在结合配体时才会转位到细胞核。我们现在证明在没有配体的情况下存在大量的核 GR,这需要核定位信号 1(NLS1)。活细胞成像显示,GR 通过有丝分裂前期进入细胞核,并在有丝分裂开始时迅速将 GR 从细胞核中排出,这种现象一直持续到早期 G1 期。这表明 GR 分布的异质性反映了细胞周期阶段。研究了细胞周期驱动的 GR 转运对一系列糖皮质激素作用的影响。在富含 G2/M 的细胞中,糖皮质激素诱导的 ERK 激活明显延长。这伴随着 DNA 模板特异性、配体非依赖性的 GR 反式激活。使用嵌合和域缺失受体,我们证明这种反式激活效应是由 AF1 反式激活结构域介导的。AF-1 含有多个磷酸化位点,这些位点是包括细胞周期蛋白依赖性激酶(CDKs)在内的激酶的共识序列,其活性在细胞周期中发生变化。在 G2/M 期,GR 在残基 203 和 211 上的磷酸化明显诱导,这两个残基在配体激活后都被磷酸化。配体非依赖性的反式激活需要诱导磷酸化的 S211GR,但不需要 S203GR,从而直接将细胞周期驱动的 GR 修饰与改变的 GR 功能联系起来。因此,细胞周期阶段调节 GR 的定位和翻译后修饰,从而选择性地影响 GR 活性。这表明细胞周期阶段是细胞对 Gc 反应的一个重要决定因素,有丝分裂指数导致组织对 Gc 的敏感性。